{"transactions":[{"id":2444625,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy","published_at":"2022-01-06T01:30:20.000Z","date":"2022-01-03","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":0,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-000802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000802/ownership.xml","form_type":"4"}},{"id":2444624,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy","published_at":"2022-01-06T01:30:20.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":10000,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-000802","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000802/ownership.xml","form_type":"4"}},{"id":2444623,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T01:30:20.000Z","date":"2022-01-03","kind":"gift","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-000802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000802/ownership.xml","form_type":"4"}},{"id":2444622,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T01:30:20.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001213900-22-000802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000802/ownership.xml","form_type":"4"}},{"id":2541839,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T21:15:17.000Z","date":"2021-07-04","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were transferred, for no consideration, to a trust with an independent trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-053085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021053085/ownership.xml","form_type":"5"}},{"id":2541838,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-15T21:15:17.000Z","date":"2021-07-04","kind":"gift","acquired":false,"shares":12191,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By wholly-owned corporation"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were transferred, for no consideration, to a trust with an independent trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-21-053085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021053085/ownership.xml","form_type":"5"}},{"id":3311773,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-14T21:04:23.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 3 installments as follows: 6,666 shall vest on December 31, 2020, and 6,667 shall vest on each of December 31, 2021 and December 31, 2022."}],"balance_after":20000,"derivative":{"exercise_price":4.8,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-000983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390020000983/ownership.xml","form_type":"4"}},{"id":3846311,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-13T20:32:34.000Z","date":"2018-08-09","kind":"purchase","acquired":true,"shares":2000,"price":4.98,"value":9960.0,"ownership":{"direct":false,"nature":"By wholly-owned corporation"},"balance_after":12191,"source":{"system":"sec-edgar","filing":"0001213900-18-010829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390018010829/ownership.xml","form_type":"4"}},{"id":3846310,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-13T20:32:34.000Z","date":"2018-08-09","kind":"purchase","acquired":true,"shares":500,"price":4.82,"value":2410.0,"ownership":{"direct":false,"nature":"By wholly-owned corporation"},"balance_after":10191,"source":{"system":"sec-edgar","filing":"0001213900-18-010829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390018010829/ownership.xml","form_type":"4"}},{"id":4264856,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-05T19:36:12.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":16773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in 3 equal installments of 5,591 on each of December 31, 2017, December 31, 2018 and December 31, 2019."}],"balance_after":16773,"derivative":{"exercise_price":7.77,"expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":16773},"source":{"system":"sec-edgar","filing":"0001213900-17-007153","document":"f4063017friedman_oramed.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017007153/f4063017friedman_oramed.xml","form_type":"4"}},{"id":4409978,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":131629,"kind":"person","name":"Friedman Aviad","position":1,"cik":"0001683729","reported_name":"Friedman Aviad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-02T20:04:36.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":4084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest immediately."}],"balance_after":4084,"derivative":{"exercise_price":1,"expiration_date":"2027-02-09","underlying":"Common Stock","underlying_shares":4084},"source":{"system":"sec-edgar","filing":"0001213900-17-001937","document":"f4020917friedman_oramed.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390017001937/f4020917friedman_oramed.xml","form_type":"4"}}]}